Module: Mutation Burden and Co-mutation
Step 1: Select Cancer and Mutation type
  
ACC: Adrenocortical Carcinoma (n=92)
BLCA: Bladder Urothelial Carcinoma (412)
BRCA: Breast Invasive Carcinoma (n=1098)
CESC: Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (n=307)
CHOL: Cholangiocarcinoma (n=51)
COAD: Colon Adenocarcinoma (n=461)
DLBC: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (n=58)
ESCA: Esophageal Carcinoma (n=185)
GBM: Glioblastoma Multiforme (n=617)
HNSC: Head and Neck Squamous Cell Carcinoma (n=528)
KICH: Kidney Chromophobe (n=113)
KIRC: Kidney Renal Clear Cell Carcinoma (n=537)
KIRP: Kidney Renal Papillary Cell Carcinoma(n=291)
LAML: Acute Myeloid Leukemia (n=200)
LGG: Brain Lower Grade Glioma (n=516)
LIHC: Liver Hepatocellular Carcinoma (n=377)
LUAD: Lung Adenocarcinoma (n=585)
LUSC: Lung Squamous Cell Carcinoma (n=504)
MESO: Mesothelioma (n=87)
OV: Ovarian Serous Cystadenocarcinoma (n=608)
PAAD: Pancreatic Adenocarcinoma (n=185)
PCPG: Pheochromocytoma and Paraganglioma (n=179)
PRAD: Prostate Adenocarcinoma (n=500)
READ: Rectum Adenocarcinoma (n=172)
SARC: Sarcoma (n=261)
SKCM: Skin Cutaneous Melanoma (n=470)
STAD: Stomach Adenocarcinoma (n=443)
TGCT: Testicular Germ Cell Tumors (n=150)
THCA: Thyroid Carcinoma (n=507)
THYM: Thymoma (n=124)
UCEC: Uterine Corpus Endometrial Carcinoma (n=560)
UCS: Uterine Carcinosarcoma (57)
UVM: Uveal Melanoma (80)


 
ACC BLCA BRCA CESC CHOL
COAD DLBC ESCA GBM HNSC
KICH KIRC KIRP LAML LGG
LIHC LUAD LUSC MESO OV
PAAD PCPG PRAD READ SARC
SKCM STAD TGCT THCA THYM
UCEC UCS UVM

Step 2: Input Genes
OR
OR




Step 3: Type of Analysis

REQUIRED
(Runtime: ~5sec per cancer for any type of analysis selected)

 Co-mutation
 Mutation Burden
 Overall Survival